Meperizumab injection

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
44	多発血管炎性肉芽腫症	1

44. 多発血管炎性肉芽腫症

臨床試験数 : 98 / 薬物数 : 108 - (DrugBank : 28) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 81

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05353179 (ClinicalTrials.gov)	June 2022	11/4/2022	Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers	Phase I, Single-center, Randomized, Double-blind, Single-dose, Parallel Comparison of Pharmacokineti ...	Granulomatosis With Polyangiitis;Hemophagocytic Syndrome	Drug: Meperizumab injection;Drug: NUCALA®	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	NULL	Not yet recruiting	18 Years	55 Years	Male	88	Early Phase 1	China

First Previous1Next Last